Article Information
History
- September 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jennifer A Shuford, MD, MPH1,
- Michael D Swartz, PhD2,
- David L Lakey, MD3,
- Kimberly A Aguillard, PhD2,
- Stephen J Pont, MD, MPH1,
- Melissa A Valerio-Shewmaker, PhD, MPH4 and
- Eric Boerwinkle, PhD2,*
- 1Texas Department of State Health Services, Austin, TX USA
- 2The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
- 3University of Texas System, Austin, TX, USA
- 4The University of Texas Health Science Center at Houston, School of Public Health in Brownsville, Brownsville, TX, USA
- ↵*Corresponding Author:
Eric Boerwinkle, PhD, Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston, School of Public Health in Houston, 1200 Pressler St. Houston, Texas 77030 (Eric.Boerwinkle{at}uth.tmc.edu) (713) 500-9058
Posted September 12, 2021.
Combined Impact of Prior SARS-CoV-2 Infection and Vaccination on Antibody Presence
